CoImmune
Latest round
- Series A
Last raised
- Nov 2020
Total raised
- $45M
Investors
- 7
About CoImmune
a. CoImmune operates as a bio-venture company that is developing various anti-cancer pipelines based on CAR-T immune cells by leveraging its two cellular platform technologies. In November 2020, Colmmune, Inc., Korea Investment Partners, Magna Investments, and W asset management. As of January 2023, Charles A. Nicolette is the CEO of the company. The company’s product line includes CARCIK (chimeric antigen receptor cytokine-induced killer)-CD19 (CMN-005), CMN-008, CAR-CIK, bi-specific CAR-CIK (AMN-006), and DC (CMN-001). CoImmune is developing CAR-CIK technology for liquid tumors and our RNA-loaded dendritic cell technology for solid tumors. As of January 2023, the firm’s CAR-CIK product is currently in clinical trials in pediatric and adult acute lymphoblastic leukemia and its dendritic cell product is in a clinical trial in advanced metastatic renal cell carcinoma.
Who invested in CoImmune
7 investors across 1 round
See all investors in CoImmune
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Nov 4, 2020
Amount
$45M
Investors
Questions about CoImmune
Who invested in CoImmune?
CoImmune has 7 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has CoImmune raised?
CoImmune has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did CoImmune last raise money?
CoImmune's most recent round on record is a Series A, in Nov 2020.
What does CoImmune do?
CoImmune is a biotechnology company.
Where is CoImmune headquartered?
CoImmune is headquartered in Durham, US.
Which VCs invest in companies like CoImmune?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at CoImmune's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like CoImmune? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.